TEVA - CIK 0000818686
TEVA PHARMACEUTICAL INDUSTRIES LTD trades as TEVA and has a market capitalization of $39.12 B, making it the #392 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $17.26B, up 4.3% from the prior year and net income of $1.41B. This page tracks TEVA PHARMACEUTICAL INDUSTRIES LTD through 2,473 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years TEVA PHARMACEUTICAL INDUSTRIES LTD's revenue declined from $21.90B to $17.26B, a compound annual decline rate of 2.6%. Net profit margin expanded from 1.5% to 8.2% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| Insider sale notice | 144 | 2026-05-14 |
| Insider sale notice | 144 | 2026-05-14 |
| Insider trade | 4 | 2026-05-07 |
| Insider trade | 4 | 2026-05-07 |
| Insider sale notice | 144 | 2026-05-05 |
| Insider sale notice | 144 | 2026-05-04 |
The European Medicines Agency Accepts Teva’s Marketing Authorization Application for Olanzapine Long-Acting Injectable (TEV-‘749) for the Treatment of Schizophrenia in Adults
Fitch Upgrades Teva to Investment Grade Amid Pivot to Growth Execution
Teva Study Finds Only 23% of Younger Adults with Mood Disorders and Tardive Dyskinesia (TD) Symptoms Are Formally Diagnosed with TD Despite Widespread Impact
The largest companies sharing TEVA PHARMACEUTICAL INDUSTRIES LTD's SEC industry classification (pharmaceutical preparations).
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) has a market capitalization of $39.12 B as of 2026-06-10, ranking #392 among US-listed companies.
TEVA PHARMACEUTICAL INDUSTRIES LTD reported revenue of $17.26B for fiscal year 2025, an increase of 4.3% year over year.
Yes. TEVA PHARMACEUTICAL INDUSTRIES LTD reported net income of $1.41B in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
Teva exceeded all sustainability-linked bond targets, linking financial performance to expanded patient access to medicines and reduced environmental impact.